Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: A pilot study View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-05-24

AUTHORS

E. Wehr, T. R. Pieber, B. Obermayer-Pietsch

ABSTRACT

Background: Women with polycystic ovary syndrome (PCOS) frequently suffer from metabolic disturbances, in particular from insulin resistance. Accumulating evidence suggests that vitamin D deficiency may contribute to the development of insulin resistance. Hence, we aimed to examine the effect of vitamin D supplementation on metabolic and endocrine parameters in PCOS women. Methods: Fifty-seven PCOS women were included in the study. PCOS women received 20,000 IU cholecalciferol weekly for 24 weeks. Anthropometric measures, oral glucose tolerance test, and blood analyses of endocrine parameters were performed at baseline and after 12 weeks (V2) and 24 weeks (V3). Results: Forty-six PCOS women finished the study. 25-hydroxyvitamin D [25(OH)D] levels significantly increased from 28.0±11.0 ng/ml at baseline to 51.3±17.3 and 52.4±21.5 at V2 and V3, respectively (p<0.001). We observed a significant decrease of fasting and stimulated glucose (V3, p<0.05) and C-peptide levels (V2 and 3, p<0.001) after vitamin D treatment. Moreover, triglyceride and estradiol levels significantly decreased at V3 (p=0.001) and V2 (p=0.022), respectively, whereas total cholesterol (V2, p=0.008) and LDL cholesterol levels (V2, p=0.005; V3, p=0.026) significantly increased after vitamin D treatment. There were no changes in androgens. At V2, 14 out of 46 PCOS women previously affected by menstrual disturbances (30.4%) reported improvement of menstrual frequency; at V3, 23 out of 46 women (50.0%), who were oligo- or amenorrheic at baseline reported improvement. Discussion: Our results suggest that vitamin D treatment might improve glucose metabolism and menstrual frequency in PCOS women. Further randomized controlled trails are warranted to confirm our findings. More... »

PAGES

757-763

Identifiers

URI

http://scigraph.springernature.com/pub.10.3275/7748

DOI

http://dx.doi.org/10.3275/7748

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1078402354

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21613813


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "C-Peptide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholecalciferol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholesterol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholesterol, LDL", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Menstruation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Menstruation Disturbances", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pilot Projects", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polycystic Ovary Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vitamin D Deficiency", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Graz, Austria", 
          "id": "http://www.grid.ac/institutes/grid.11598.34", 
          "name": [
            "Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Graz, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wehr", 
        "givenName": "E.", 
        "id": "sg:person.0754156424.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754156424.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Graz, Austria", 
          "id": "http://www.grid.ac/institutes/grid.11598.34", 
          "name": [
            "Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Graz, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pieber", 
        "givenName": "T. R.", 
        "id": "sg:person.0757263437.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757263437.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Graz, Austria", 
          "id": "http://www.grid.ac/institutes/grid.11598.34", 
          "name": [
            "Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Graz, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Obermayer-Pietsch", 
        "givenName": "B.", 
        "id": "sg:person.01071524655.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071524655.82"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00508-009-1162-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024936200", 
          "https://doi.org/10.1007/s00508-009-1162-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00394-008-0700-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010314697", 
          "https://doi.org/10.1007/s00394-008-0700-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03345785", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000137059", 
          "https://doi.org/10.1007/bf03345785"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng0897-391", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051287855", 
          "https://doi.org/10.1038/ng0897-391"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10552-009-9466-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014644603", 
          "https://doi.org/10.1007/s10552-009-9466-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00404-009-0958-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040584890", 
          "https://doi.org/10.1007/s00404-009-0958-7"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-05-24", 
    "datePublishedReg": "2011-05-24", 
    "description": "Background: Women with polycystic ovary syndrome (PCOS) frequently suffer from metabolic disturbances, in particular from insulin resistance. Accumulating evidence suggests that vitamin D deficiency may contribute to the development of insulin resistance. Hence, we aimed to examine the effect of vitamin D supplementation on metabolic and endocrine parameters in PCOS women. Methods: Fifty-seven PCOS women were included in the study. PCOS women received 20,000 IU cholecalciferol weekly for 24 weeks. Anthropometric measures, oral glucose tolerance test, and blood analyses of endocrine parameters were performed at baseline and after 12 weeks (V2) and 24 weeks (V3). Results: Forty-six PCOS women finished the study. 25-hydroxyvitamin D [25(OH)D] levels significantly increased from 28.0\u00b111.0 ng/ml at baseline to 51.3\u00b117.3 and 52.4\u00b121.5 at V2 and V3, respectively (p<0.001). We observed a significant decrease of fasting and stimulated glucose (V3, p<0.05) and C-peptide levels (V2 and 3, p<0.001) after vitamin D treatment. Moreover, triglyceride and estradiol levels significantly decreased at V3 (p=0.001) and V2 (p=0.022), respectively, whereas total cholesterol (V2, p=0.008) and LDL cholesterol levels (V2, p=0.005; V3, p=0.026) significantly increased after vitamin D treatment. There were no changes in androgens. At V2, 14 out of 46 PCOS women previously affected by menstrual disturbances (30.4%) reported improvement of menstrual frequency; at V3, 23 out of 46 women (50.0%), who were oligo- or amenorrheic at baseline reported improvement. Discussion: Our results suggest that vitamin D treatment might improve glucose metabolism and menstrual frequency in PCOS women. Further randomized controlled trails are warranted to confirm our findings.", 
    "genre": "article", 
    "id": "sg:pub.10.3275/7748", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.7580457", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1088396", 
        "issn": [
          "0391-4097", 
          "1720-8386"
        ], 
        "name": "Journal of Endocrinological Investigation", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "10", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "34"
      }
    ], 
    "keywords": [
      "vitamin D treatment", 
      "PCOS women", 
      "polycystic ovary syndrome", 
      "menstrual frequency", 
      "insulin resistance", 
      "endocrine parameters", 
      "glucose metabolism", 
      "polycystic ovary syndrome women", 
      "D treatment", 
      "oral glucose tolerance test", 
      "vitamin D supplementation", 
      "vitamin D deficiency", 
      "C-peptide levels", 
      "vitamin D3 treatment", 
      "LDL cholesterol levels", 
      "glucose tolerance test", 
      "D supplementation", 
      "D deficiency", 
      "menstrual disturbances", 
      "ovary syndrome", 
      "total cholesterol", 
      "estradiol levels", 
      "tolerance test", 
      "D levels", 
      "metabolic disturbances", 
      "cholesterol levels", 
      "D3 treatment", 
      "anthropometric measures", 
      "blood analysis", 
      "pilot study", 
      "women", 
      "significant decrease", 
      "baseline", 
      "weeks", 
      "treatment", 
      "metabolism", 
      "levels", 
      "syndrome", 
      "androgens", 
      "triglycerides", 
      "IU", 
      "cholesterol", 
      "supplementation", 
      "study", 
      "V3", 
      "glucose", 
      "deficiency", 
      "V2", 
      "effect", 
      "disturbances", 
      "resistance", 
      "improvement", 
      "frequency", 
      "findings", 
      "evidence", 
      "decrease", 
      "measures", 
      "test", 
      "changes", 
      "trails", 
      "development", 
      "oligo", 
      "analysis", 
      "results", 
      "parameters"
    ], 
    "name": "Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: A pilot study", 
    "pagination": "757-763", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1078402354"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.3275/7748"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21613813"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.3275/7748", 
      "https://app.dimensions.ai/details/publication/pub.1078402354"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:37", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_556.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.3275/7748"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.3275/7748'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.3275/7748'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.3275/7748'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.3275/7748'


 

This table displays all metadata directly associated to this object as RDF triples.

229 TRIPLES      21 PREDICATES      112 URIs      98 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.3275/7748 schema:about N0d9dd43b566a41b2860784dcf956f6a3
2 N4b38f6d5023c4fa3901223f8d6d2b3e7
3 N4bbd29958fea4e0bb7be7f88eb9c3400
4 N5f2db5d69643482dba0893c5d1320012
5 N6e1db1ae4eff431a8b6515e17392e37e
6 N6fd4dae8634443fc8628e4cd8cc55e88
7 N7443d2edad354e39ac32f543c385d8df
8 N8ce636ab3799428a9851430087a46c8b
9 N9a8da111964447d693f3b3e665146768
10 Na17c3bace9644560857ceca677902c61
11 Na46a1330e3554da8805c6723f5f1c347
12 Nab3c47eb1a0d4e1f81c46dd493fca6d4
13 Nb93abb6979c34ef09e27f2cc189e4536
14 Nd14abc3f120a412e9e8f3f1a1e164e27
15 Ne584635d0d90493c8c4102099bf203dc
16 Nf528aadf55684e1cafd0c42bc165fe0f
17 anzsrc-for:11
18 anzsrc-for:1103
19 schema:author N1e1d229e82b9400ba0a3ed8b38c451cf
20 schema:citation sg:pub.10.1007/bf03345785
21 sg:pub.10.1007/s00394-008-0700-4
22 sg:pub.10.1007/s00404-009-0958-7
23 sg:pub.10.1007/s00508-009-1162-2
24 sg:pub.10.1007/s10552-009-9466-0
25 sg:pub.10.1038/ng0897-391
26 schema:datePublished 2011-05-24
27 schema:datePublishedReg 2011-05-24
28 schema:description Background: Women with polycystic ovary syndrome (PCOS) frequently suffer from metabolic disturbances, in particular from insulin resistance. Accumulating evidence suggests that vitamin D deficiency may contribute to the development of insulin resistance. Hence, we aimed to examine the effect of vitamin D supplementation on metabolic and endocrine parameters in PCOS women. Methods: Fifty-seven PCOS women were included in the study. PCOS women received 20,000 IU cholecalciferol weekly for 24 weeks. Anthropometric measures, oral glucose tolerance test, and blood analyses of endocrine parameters were performed at baseline and after 12 weeks (V2) and 24 weeks (V3). Results: Forty-six PCOS women finished the study. 25-hydroxyvitamin D [25(OH)D] levels significantly increased from 28.0±11.0 ng/ml at baseline to 51.3±17.3 and 52.4±21.5 at V2 and V3, respectively (p<0.001). We observed a significant decrease of fasting and stimulated glucose (V3, p<0.05) and C-peptide levels (V2 and 3, p<0.001) after vitamin D treatment. Moreover, triglyceride and estradiol levels significantly decreased at V3 (p=0.001) and V2 (p=0.022), respectively, whereas total cholesterol (V2, p=0.008) and LDL cholesterol levels (V2, p=0.005; V3, p=0.026) significantly increased after vitamin D treatment. There were no changes in androgens. At V2, 14 out of 46 PCOS women previously affected by menstrual disturbances (30.4%) reported improvement of menstrual frequency; at V3, 23 out of 46 women (50.0%), who were oligo- or amenorrheic at baseline reported improvement. Discussion: Our results suggest that vitamin D treatment might improve glucose metabolism and menstrual frequency in PCOS women. Further randomized controlled trails are warranted to confirm our findings.
29 schema:genre article
30 schema:isAccessibleForFree false
31 schema:isPartOf N74f41cd112df4ec8adad21d2f4a32a60
32 Nc0cbba7b3030467cada2eb8a2b858cfd
33 sg:journal.1088396
34 schema:keywords C-peptide levels
35 D deficiency
36 D levels
37 D supplementation
38 D treatment
39 D3 treatment
40 IU
41 LDL cholesterol levels
42 PCOS women
43 V2
44 V3
45 analysis
46 androgens
47 anthropometric measures
48 baseline
49 blood analysis
50 changes
51 cholesterol
52 cholesterol levels
53 decrease
54 deficiency
55 development
56 disturbances
57 effect
58 endocrine parameters
59 estradiol levels
60 evidence
61 findings
62 frequency
63 glucose
64 glucose metabolism
65 glucose tolerance test
66 improvement
67 insulin resistance
68 levels
69 measures
70 menstrual disturbances
71 menstrual frequency
72 metabolic disturbances
73 metabolism
74 oligo
75 oral glucose tolerance test
76 ovary syndrome
77 parameters
78 pilot study
79 polycystic ovary syndrome
80 polycystic ovary syndrome women
81 resistance
82 results
83 significant decrease
84 study
85 supplementation
86 syndrome
87 test
88 tolerance test
89 total cholesterol
90 trails
91 treatment
92 triglycerides
93 vitamin D deficiency
94 vitamin D supplementation
95 vitamin D treatment
96 vitamin D3 treatment
97 weeks
98 women
99 schema:name Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: A pilot study
100 schema:pagination 757-763
101 schema:productId N030ca4cf709945a591a5422fb2ef73f8
102 N34f4e872817d41d1b660e0c798728d1f
103 N4b324f5047e7424887d8ded9c6aff4df
104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078402354
105 https://doi.org/10.3275/7748
106 schema:sdDatePublished 2022-10-01T06:37
107 schema:sdLicense https://scigraph.springernature.com/explorer/license/
108 schema:sdPublisher N1e2571da0ede423c8db5d6a6ec219b0a
109 schema:url https://doi.org/10.3275/7748
110 sgo:license sg:explorer/license/
111 sgo:sdDataset articles
112 rdf:type schema:ScholarlyArticle
113 N030ca4cf709945a591a5422fb2ef73f8 schema:name pubmed_id
114 schema:value 21613813
115 rdf:type schema:PropertyValue
116 N0d9dd43b566a41b2860784dcf956f6a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Blood Glucose
118 rdf:type schema:DefinedTerm
119 N1e1d229e82b9400ba0a3ed8b38c451cf rdf:first sg:person.0754156424.63
120 rdf:rest N471e85db250c4312963e4a4d606d6cef
121 N1e2571da0ede423c8db5d6a6ec219b0a schema:name Springer Nature - SN SciGraph project
122 rdf:type schema:Organization
123 N2841afae408649ee95a1f9fe7dff2385 rdf:first sg:person.01071524655.82
124 rdf:rest rdf:nil
125 N34f4e872817d41d1b660e0c798728d1f schema:name doi
126 schema:value 10.3275/7748
127 rdf:type schema:PropertyValue
128 N471e85db250c4312963e4a4d606d6cef rdf:first sg:person.0757263437.98
129 rdf:rest N2841afae408649ee95a1f9fe7dff2385
130 N4b324f5047e7424887d8ded9c6aff4df schema:name dimensions_id
131 schema:value pub.1078402354
132 rdf:type schema:PropertyValue
133 N4b38f6d5023c4fa3901223f8d6d2b3e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Menstruation Disturbances
135 rdf:type schema:DefinedTerm
136 N4bbd29958fea4e0bb7be7f88eb9c3400 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Pilot Projects
138 rdf:type schema:DefinedTerm
139 N5f2db5d69643482dba0893c5d1320012 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Humans
141 rdf:type schema:DefinedTerm
142 N6e1db1ae4eff431a8b6515e17392e37e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Menstruation
144 rdf:type schema:DefinedTerm
145 N6fd4dae8634443fc8628e4cd8cc55e88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Adolescent
147 rdf:type schema:DefinedTerm
148 N7443d2edad354e39ac32f543c385d8df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name C-Peptide
150 rdf:type schema:DefinedTerm
151 N74f41cd112df4ec8adad21d2f4a32a60 schema:issueNumber 10
152 rdf:type schema:PublicationIssue
153 N8ce636ab3799428a9851430087a46c8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Administration, Oral
155 rdf:type schema:DefinedTerm
156 N9a8da111964447d693f3b3e665146768 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Vitamin D Deficiency
158 rdf:type schema:DefinedTerm
159 Na17c3bace9644560857ceca677902c61 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Cholesterol
161 rdf:type schema:DefinedTerm
162 Na46a1330e3554da8805c6723f5f1c347 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Female
164 rdf:type schema:DefinedTerm
165 Nab3c47eb1a0d4e1f81c46dd493fca6d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Adult
167 rdf:type schema:DefinedTerm
168 Nb93abb6979c34ef09e27f2cc189e4536 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Cholecalciferol
170 rdf:type schema:DefinedTerm
171 Nc0cbba7b3030467cada2eb8a2b858cfd schema:volumeNumber 34
172 rdf:type schema:PublicationVolume
173 Nd14abc3f120a412e9e8f3f1a1e164e27 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Prospective Studies
175 rdf:type schema:DefinedTerm
176 Ne584635d0d90493c8c4102099bf203dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Polycystic Ovary Syndrome
178 rdf:type schema:DefinedTerm
179 Nf528aadf55684e1cafd0c42bc165fe0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Cholesterol, LDL
181 rdf:type schema:DefinedTerm
182 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
183 schema:name Medical and Health Sciences
184 rdf:type schema:DefinedTerm
185 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
186 schema:name Clinical Sciences
187 rdf:type schema:DefinedTerm
188 sg:grant.7580457 http://pending.schema.org/fundedItem sg:pub.10.3275/7748
189 rdf:type schema:MonetaryGrant
190 sg:journal.1088396 schema:issn 0391-4097
191 1720-8386
192 schema:name Journal of Endocrinological Investigation
193 rdf:type schema:Periodical
194 sg:person.01071524655.82 schema:affiliation grid-institutes:grid.11598.34
195 schema:familyName Obermayer-Pietsch
196 schema:givenName B.
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071524655.82
198 rdf:type schema:Person
199 sg:person.0754156424.63 schema:affiliation grid-institutes:grid.11598.34
200 schema:familyName Wehr
201 schema:givenName E.
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754156424.63
203 rdf:type schema:Person
204 sg:person.0757263437.98 schema:affiliation grid-institutes:grid.11598.34
205 schema:familyName Pieber
206 schema:givenName T. R.
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757263437.98
208 rdf:type schema:Person
209 sg:pub.10.1007/bf03345785 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000137059
210 https://doi.org/10.1007/bf03345785
211 rdf:type schema:CreativeWork
212 sg:pub.10.1007/s00394-008-0700-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010314697
213 https://doi.org/10.1007/s00394-008-0700-4
214 rdf:type schema:CreativeWork
215 sg:pub.10.1007/s00404-009-0958-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040584890
216 https://doi.org/10.1007/s00404-009-0958-7
217 rdf:type schema:CreativeWork
218 sg:pub.10.1007/s00508-009-1162-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024936200
219 https://doi.org/10.1007/s00508-009-1162-2
220 rdf:type schema:CreativeWork
221 sg:pub.10.1007/s10552-009-9466-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014644603
222 https://doi.org/10.1007/s10552-009-9466-0
223 rdf:type schema:CreativeWork
224 sg:pub.10.1038/ng0897-391 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051287855
225 https://doi.org/10.1038/ng0897-391
226 rdf:type schema:CreativeWork
227 grid-institutes:grid.11598.34 schema:alternateName Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Graz, Austria
228 schema:name Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Graz, Austria
229 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...